Edgewise Therapeutics, Inc. (EWTX)

SEC filing

Edgewise Therapeutics, Inc.

EWTX · CIK 1710072

4 · Aug 14, 2026 · General Counsel MOORE JOHN R sold 5,016 shares at $43.82/share ($219.8K); exercised options for 25.00K shares; was granted 97.50K shares

General Counsel MOORE JOHN R sold 5,016 shares at $43.82/share ($219.8K); exercised options for 25.00K shares; was granted 97.50K shares

Filed: Aug 14, 2026
Period: Aug 12, 2026
Accession: 0001191702-26-000001
Filer: Edgewise Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

PRIMARY DOCUMENT

xslF345X06/primarydocument.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4PRIMARY DOCUMENTprimarydocument.xml
Open SEC.gov